transplantable retinal epithelial cells (GenVec)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametransplantable retinal epithelial cells (GenVec)
Drug Alias Namecell therapy (Diacrin)porcine RPE cells (Diacrin)transplantable retinal epithelial cells (Diacrin)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiacrin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenVec IncDiacrin
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A